ARQCapital, a Philippines-based investment firm focused on providing growth capital, announced that it has invested in Medline, a dialysis chain operator and franchising pioneer in the country. Financial details of the investment were not disclosed.
ARQCapital, established in 2014 by Edmund Solilapsi and Abigail Tan, said Medline will use the investment to build new free-standing affordable dialysis centres.
The investment comes on the heels of the rising need for dialysis treatment in the Philippines. According to the National Kidney and Transplant Institute, one citizen every hour — or about 120 Filipinos per million population per year — develop chronic renal failure.
The country’s Department of Health also estimates that the number of cases of kidney diseases is increasing at a rate of 10 to 15 per cent each year.
However, only 2 in 3 patients diagnosed with end-stage renal disease are going through dialysis due to the cost of treatment and the shortage of dialysis centres in the country, ARQCapital said. Medline was established in 2015 by brothers Alexander and Bong Lim, with the aim of becoming one of the major players in the highly fragmented $300-million Philippines hemodialysis market.
Medline was established in 2015 by brothers Alexander and Bong Lim, with the aim of becoming one of the major players in the highly fragmented $300-million Philippines hemodialysis market.
South Africa Today
Read more at VolaNews
